암 종양 프로파일링 시장 보고서(2035년)

Cancer tumor profiling refers to the comprehensive molecular and genetic analysis of cancerous tissues to identify specific mutations, gene expressions, protein markers, epigenetic modifications and other biological characteristics associated with a tumor. It is used to characterize the molecular architecture of cancer and to guide clinical and research decision-making in oncology.

The cancer tumor profiling market consists of sales by entities (organizations, sole traders and partnerships) of cancer tumor profiling that are used by oncologists, pathologists, molecular biologists, academic researchers, pharmaceutical and biotechnology companies and contract research organizations. It is applied at the time of initial diagnosis to classify tumor subtypes, during treatment selection to identify actionable targets, throughout therapy to monitor response or resistance and at recurrence to reassess tumor evolution.

The global cancer tumor profiling market was valued at $8,093.5 million in 2020 which grew till 2025 at a compound annual growth rate (CAGR) of more than 13.00%.

Rising Global Cancer Incidence

During the historic period, the cancer tumor profiling market was significantly driven by the rising global cancer incidence. Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells that can invade surrounding tissues and potentially spread to other parts of the body. One key factor contributing to the rising incidence of cancer is the aging population, as the likelihood of genetic mutations and cellular damage increases with age. With longer life expectancy worldwide, more individuals fall into high-risk age groups, leading to a greater number of cancer cases. Cancer tumor profiling supports cancer management by analyzing the molecular and genetic characteristics of tumors, enabling deeper understanding of tumor behavior and guiding more informed clinical decision-making. For example, in February 2024, according to the WHO (World Health Organization), a specialized agency of the United Nations which coordinates responses to international public health issues and emergencies, in 2022, there were an estimated 20 million new cancer cases and 9.7 million deaths. The estimated number of people who were alive within 5 years following a cancer diagnosis was 53.5 million. About 1 in 5 people develop cancer in their lifetime, approximately 1 in 9 men and 1 in 12 women die from the disease. , over 2 million new cancer cases are projected for the U.S. in 2024. Therefore, the cancer tumor profiling market was significantly driven by the rising global cancer incidence during the historic period.

Biotechnology, Genomics And Precision Medicine

Major companies in the cancer tumor profiling market are increasingly prioritizing biotechnology, genomics and precision medicine to enhance the accuracy, depth and clinical relevance of molecular diagnostics. By integrating advanced sequencing technologies, multi-omics platforms and AI-driven analytics, they aim to deliver comprehensive insights into tumor biology and actionable genetic alterations. Biotechnology, genomics and precision medicine play a critical role in advancing cancer tumor profiling by enabling detailed molecular characterization of tumors at the DNA, RNA and protein levels. Advanced sequencing technologies, such as next-generation sequencing and multi-omics platforms, allow for the identification of genetic mutations, biomarkers and pathway alterations that drive cancer progression. Precision medicine frameworks use these insights to guide targeted therapy selection, optimize treatment response and minimize unnecessary interventions. Biotechnology innovations further support the development of high-sensitivity assays, including liquid biopsy and companion diagnostics, enhancing early detection and disease monitoring. Collectively, these advancements are reshaping the cancer tumor profiling landscape by shifting it from conventional histopathological analysis toward data-driven, personalized oncology solutions that improve clinical decision-making and patient outcomes.

The global cancer tumor profiling market is fragmented, with a large number of small players operating in the market. The top 10 competitors in the market made up 14.070% of the total market in 2024.

Cancer Tumor Profiling Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global cancer tumor profiling market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for cancer tumor profiling? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cancer tumor profiling market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider cancer tumor profiling market; and compares it with other markets.

The report covers the following chapters

• Introduction And Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segments, key products, supply chain and market attractiveness scoring and analysis.
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future technologies and developments in the market.
• Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
• Regional And Country Analysis- Historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2020-2025) (2025-2030, 2035F) and analysis for each segment by cancer type, by technology, by process type and by application in the market. Historic (2020-2025) and forecast (2025-2030) and (2030-2035) market values and growth and market share comparison by region market.
• Regional Market Size And Growth- Regional market size (2025), historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies- Details on the startups, company profiles of other major and innovative companies in the market.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
• Recent Developments- Information on recent developments in the market covered in the report.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for cancer tumor profiling providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Cancer Type: Lung Cancer; Breast Cancer; Colorectal Cancer; Prostate Cancer; Melanoma; Ovarian Cancer; Stomach Cancer; Pancreatic Cancer; Thyroid Cancer; Other Cancer Types
• 2) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Immunohistochemistry (IHC); In Situ Hybridization (ISH); Microarray; Other Technologies
• 3) By Process Type: Genomics; Proteomics; Epigenetics; Other Types
• 4) By Application: Personalized Medicine; Diagnostics; Biomarker Discovery; Prognostics; Research Applications
• Companies Mentioned: Illumina Inc.; Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche Ltd. (Foundation Medicine); Caris Life Sciences Inc.; QIAGEN N.V.
• Countries: China; Australia; India; Indonesia; Japan; South Korea; Taiwan; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; cancer tumor profiling indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes."

Table of Contents

1 Executive Summary

• 1.1 Dashboard

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Cancer Tumor Profiling Market Definition And Segmentations
• 6.4 Market Segmentation By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer And Other Cancer Types)
• 6.5 Market Segmentation By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarray and Other Technologies)
• 6.6 Market Segmentation By Process Type (Genomics, Proteomics, Epigenetics And Other Types)
• 6.7 Market Segmentation By Application (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics And Research Applications)

7 Cancer Tumor Profiling Market, Overview Of Key Products/Services

• 7.1 Global Cancer Tumor Profiling Market Attractiveness Scoring And Analysis
  • 7.1.1 Overview Of Market Attractiveness Framework
  • 7.1.2 Quantitative Scoring Methodology
  • 7.1.3 Market Attractiveness Scoring And Interpretation
  • 7.1.4 Factor-Wise Evaluation
  • 7.1.5 Strategic Implications And Recommendations

8 Major Market Trends

• 8.1 Key Technologies & Future Trends
  • 8.1.1 Biotechnology, Genomics And Precision Medicine
  • 8.1.2 Artificial Intelligence And Autonomous Intelligence
  • 8.1.3 Digitalization, Cloud, Big Data And Cybersecurity
  • 8.1.4 Industry 4.0 And Intelligent Manufacturing
  • 8.1.5 Internet of Things (IoT), Smart Infrastructure And Connected Ecosystems
• 8.2 Major Trends
  • 8.2.1 Liquid Biopsy Multi-Gene Panel For Comprehensive Genomic Profiling
  • 8.2.2 Emergence Of Hybrid Capture-Based Comprehensive Oncology Sequencing Platforms
  • 8.2.3 Advanced Multi-Gene Cancer Profiling Solution For Precision Oncology
  • 8.2.4 Emergence Of Whole Exome Sequencing-Based Tumor Profiling Assays

9 Global Cancer Tumor Profiling Growth Analysis And Strategic Analysis Framework

• 9.1 Global Cancer Tumor Profiling PESTEL Analysis
  • 9.1.1 Political
  • 9.1.2 Economic
  • 9.1.3 Social
  • 9.1.4 Technological
  • 9.1.5 Environmental
  • 9.1.6 Legal
• 9.2 Analysis Of End User (B2B)
  • 9.2.1 Hospitals And Cancer Treatment Centers
  • 9.2.2 Diagnostic Laboratories And Pathology Labs
  • 9.2.3 Pharmaceutical And Biopharmaceutical Companies
  • 9.2.4 Academic And Research Institutes
  • 9.2.5 Contract Research Organizations (Cros)
• 9.3 Global Cancer Tumor Profiling Market Size And Growth Analysis
• 9.4 Historic Market Growth, 2020 - 2025, Value ($ Million)
  • 9.4.1 Market Drivers 2020 - 2025
  • 9.4.2 Market Restraints 2020 - 2025
• 9.5 Forecast Market Growth, 2025 - 2030, 2035F Value ($ Million)
• 9.6 Forecast Growth Contributors/Factors
  • 9.6.1 Quantitative Growth Contributors
  • 9.6.2 Drivers
  • 9.6.3 Restraints

10 Global Cancer Tumor Profiling Total Addressable Market (TAM) Analysis

• 10.1 Definition And Scope of Total Addressable Market (TAM)
• 10.2 Methodology And Assumptions
  • 10.2.1 Total Addressable Market for the Cancer Tumor Profiling Market - Business to Customer (B2C)
  • 10.2.2 TAM Comparison Analysis

11 Global Cancer Tumor Profiling Market Segmentation

• 11.1 Global Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.2 Global Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.3 Global Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.4 Global Cancer Tumor Profiling Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.5 Global Cancer Tumor Profiling Market, Sub Segmentation Of Lung Cancer, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.6 Global Cancer Tumor Profiling Market, Sub-Segmentation Of Breast Cancer, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.7 Global Cancer Tumor Profiling Market, Sub-Segmentation Of Colorectal Cancer, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.8 Global Cancer Tumor Profiling Market, Sub-Segmentation Of Prostate Cancer, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.9 Global Cancer Tumor Profiling Market, Sub-Segmentation Of Melanoma, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.10 Global Cancer Tumor Profiling Market, Sub-Segmentation Of Ovarian Cancer, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.11 Global Cancer Tumor Profiling Market, Sub-Segmentation Of Stomach Cancer, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.12 Global Cancer Tumor Profiling Market, Sub-Segmentation Of Pancreatic Cancer, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.13 Global Cancer Tumor Profiling Market, Sub-Segmentation Of Thyroid Cancer, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.14 Global Cancer Tumor Profiling Market, Sub-Segmentation Of Other Cancer Types, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

12 Cancer Tumor Profiling Market, Regional and Country Analysis

• 12.1 Global Cancer Tumor Profiling Market, By Region, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.2 Global Cancer Tumor Profiling Market, By Country, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

13 Asia-Pacific Market

• 13.1 Asia-Pacific Market Summary
  • 13.1.1 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 13.2 Asia-Pacific Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.3 Asia-Pacific Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.4 Asia-Pacific Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.5 China Market
  • 13.5.1 China Market Summary
  • 13.5.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 13.5.3 China Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.5.4 China Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.5.5 China Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.6 India Market
  • 13.6.1 India Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.6.2 India Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.6.3 India Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.7 Japan Market
  • 13.7.1 Japan Market Summary
  • 13.7.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 13.7.3 Japan Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.7.4 Japan Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.7.5 Japan Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.8 Australia Market
  • 13.8.1 Australia Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.8.2 Australia Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.8.3 Australia Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.9 South Korea Market
  • 13.9.1 South Korea Market Summary
  • 13.9.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 13.9.3 South Korea Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.9.4 South Korea Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.9.5 South Korea Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.10 Taiwan Market
  • 13.10.1 Taiwan Market Summary
  • 13.10.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 13.10.3 Taiwan Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.10.4 Taiwan Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.10.5 Taiwan Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

14 South East Asia Market

• 14.1 South East Asia Market Summary
• 14.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 14.2.1 South East Asia Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 14.2.2 South East Asia Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 14.2.3 South East Asia Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.3 Indonesia Market
  • 14.3.1 Indonesia Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 14.3.2 Indonesia Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 14.3.3 Indonesia Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

15 Western Europe Market

• 15.1 Western Europe Market Summary
  • 15.1.1 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 15.2 Western Europe Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.3 Western Europe Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.4 Western Europe Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.5 UK Market
  • 15.5.1 UK Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.5.2 UK Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.5.3 UK Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.6 Germany Market
  • 15.6.1 Germany Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.6.2 Germany Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.6.3 Germany Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.7 France Market
  • 15.7.1 France Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.7.2 France Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.7.3 France Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.8 Italy Market
  • 15.8.1 Italy Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.8.2 Italy Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.8.3 Italy Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.9 Spain Market
  • 15.9.1 Spain Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.9.2 Spain Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.9.3 Spain Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

16 Eastern Europe Market

• 16.1 Eastern Europe Market Summary
• 16.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 16.3 Eastern Europe Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.4 Eastern Europe Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.5 Eastern Europe Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.6 Russia Market
  • 16.6.1 Russia Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.6.2 Russia Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.6.3 Russia Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

17 North America Market

• 17.1 North America Market Summary
• 17.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 17.3 North America Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.4 North America Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.5 North America Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.6 USA Market
  • 17.6.1 USA Market Summary
  • 17.6.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 17.6.3 USA Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.6.4 USA Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.6.5 USA Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.7 Canada Market
  • 17.7.1 Canada Market Summary
  • 17.7.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 17.7.3 Canada Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.7.4 Canada Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.7.5 Canada Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

18 South America Market

• 18.1 South America Market Summary
• 18.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 18.3 South America Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.4 South America Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.5 South America Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.6 Brazil Market
  • 18.6.1 Brazil Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.6.2 Brazil Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.6.3 Brazil Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

19 Middle East Market

• 19.1 Middle East Market Summary
• 19.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 19.3 Middle East Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.4 Middle East Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.5 Middle East Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

20 Africa Market

• 20.1 Africa Market Summary
• 20.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 20.3 Africa Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.4 Africa Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.5 Africa Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

21 Competitive Landscape And Company Profiles

• 21.1 Cancer Tumor Profiling Market Competitive Landscape And & Market Share 2024
  • 21.1.1 Top 10 Companies (Ranked by revenue/share)
• 21.2 Company Profiles
• 21.3 Illumina Inc (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 21.4 Thermo Fisher Scientific Inc (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 21.5 F. Hoffmann-La Roche Ltd. (Foundation Medicine) (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 21.6 Caris Life Sciences Inc (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 21.7 Qiagen N.V. (Company Overview, Products and Services, Business Strategy, Financial Overview)

22 Other Major And Innovative Companies

• 22.1 Tempus AI Inc.
• 22.2 NeoGenomics Laboratories Inc.
• 22.3 Exact Sciences Corporation
• 22.4 Myriad Genetics Inc.
• 22.5 Veracyte Inc.
• 22.6 Bio-Rad Laboratories Inc.
• 22.7 Sysmex Corporation
• 22.8 Guardant Health Inc.
• 22.9 Hologic Inc.
• 22.10 Invitae Corporation
• 22.11 Natera Inc.
• 22.12 NantHealth Inc.
• 22.13 RareCyte Inc.
• 22.14 Personal Genome Diagnostics Inc.
• 22.15 Strand Life Sciences Pvt. Ltd.

23 Competitive Benchmarking

24 Competitive Dashboard

25 Cancer Tumor Profiling Market - Company Scoring Matrix

• 25.1 Innovation & Brand Leaders
• 25.2 Emerging Innovators
• 25.3 Brand-Driven Traditionalists
• 25.4 Niche or Local Followers

26 Upcoming Startups In the Market

27 Key Mergers And Acquisitions

• 27.1 Natera Acquired Foresight Diagnostics
• 27.2 Quest Diagnostics Acquired Haystack Oncology

28 Recent Developments

• 28.1 AI Insights Signature Launched For Breast Cancer Treatment Personalization
• 28.2 Multiomic Tissue Profiling Test Launched For Precision Oncology

29 Opportunities And Strategies

• 29.1 Global Cancer Tumor Profiling Market In 2030 - Countries Offering Most New Opportunities
• 29.2 Global Cancer Tumor Profiling Market In 2030 - Segments Offering Most New Opportunities
• 29.3 Global Cancer Tumor Profiling Market In 2030 - Growth Strategies
  • 29.3.1 Market Trend Based Strategies
  • 29.3.2 Competitor Strategies

30 Cancer Tumor Profiling Market, Conclusions And Recommendations

• 30.1 Conclusions
• 30.2 Recommendations
  • 30.2.1 Product
  • 30.2.2 Place
  • 30.2.3 Price
  • 30.2.4 Promotion
  • 30.2.5 People

31 Appendix

• 31.1 Geographies Covered
• 31.2 Market Data Sources
• 31.3 Research Methodology
• 31.4 Currencies
• 31.5 The Business Research Company
• 31.6 Copyright and Disclaimer